Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
ASX falls as investors trade cautiously ahead of busy week

2018-07-16 theage.com.au
The Australian sharemarket has started the week's trading lower with investors remaining cautious ahead of a busy week on the market.
BGCHY RIO BLT RIO BHPBF BGA GEM MS.PRE MS.PRF MS.PRG MS.PRA RTPPF MS.PRI BHP MS.PRK RIO RTNTF BBL BHP MS BHPLF

2
ASX falls as investors trade cautiously ahead of busy week

2018-07-16 smh.com.au
The Australian sharemarket has started the week's trading lower with investors remaining cautious ahead of a busy week on the market.
BGCHY RIO BLT RIO BHPBF BGA GEM MS.PRE MS.PRF MS.PRG MS.PRA RTPPF MS.PRI BHP MS.PRK RIO RTNTF BBL BHP MS BHPLF

0
Chinese investment in Queensland healthcare on the rise

2018-06-12 smh.com.au
Queensland is becoming an increasingly popular location for Chinese investors, with more than half of their state-based investments being put into the healthcare sector.
GEM

0
G8 Education expects new funding package to counteract falling occupancy rates

2018-05-03 proactiveinvestors.com.au
G8 Education Ltd (ASX:GEM) notes the supply environment continues to be challenging in childcare, with like-for-like (LFL) occupancy down around 2.5 to 3% so far in 2018.
GEM

0
G8 Education notes falling occupancy but new funding package to counteract

2018-05-03 proactiveinvestors.com.au
G8 Education Ltd (ASX:GEM) notes the supply environment continues to be challenging in childcare, with like-for-like (LFL) occupancy down around 2.5 to 3% so far in 2018.
GEM

28
Markets Live: ASX climbing higher on banks

2018-04-30 theage.com.au
Coronado Coal has hired Goldman Sachs, UBS and Bell Potter Securities to oversee an initial public offering of its Australian and United States assets.
BLT BHP BHPBF GEM BBL BHP BHPLF WNARF WSA

28
Markets Live: ASX climbing higher on banks

2018-04-30 smh.com.au
Coronado Coal has hired Goldman Sachs, UBS and Bell Potter Securities to oversee an initial public offering of its Australian and United States assets.
BLT BHP BHPBF GEM BBL BHP BHPLF WNARF WSA

5
Australian tech wreck Yuuzoo under Singapore police investigation

2018-04-08 theage.com.au
It’s getting a bit sticky at Australian-founded, Singapore-listed tech group Yuuzoo, set up by Sydney music entrepreneur Ron Creevey and former Nokia Asia Pacific chief executive Thomas Zilliacus.
SPXCY SPXCF GEM S68

5
Australian tech wreck Yuuzoo under Singapore police investigation

2018-04-08 smh.com.au
It’s getting a bit sticky at Australian-founded, Singapore-listed tech group Yuuzoo, set up by Sydney music entrepreneur Ron Creevey and former Nokia Asia Pacific chief executive Thomas Zilliacus.
SPXCY SPXCF GEM S68

12
ASX rallies late to finish day's trading firmer, breaking a stretch of declines

2018-04-04 theage.com.au
Australian shares rose on Wednesday, avoiding a fourth straight day of losses. Predictions of a strong start to the day after a strong close on Wall Street were proven wrong but the market was able to recover throughout the day with the S&P/ASX 200 index ending up 0.2 per cent at 5761.4 points.
SNDFY GEM MS.PRE MS.PRF MS.PRG MS.PRA RFG MS.PRI SFRRF MS.PRK SFR RFGPF MS WNARF WSA

12
ASX rallies late to finish day's trading firmer, breaking a stretch of declines

2018-04-04 smh.com.au
Australian shares rose on Wednesday, avoiding a fourth straight day of losses. Predictions of a strong start to the day after a strong close on Wall Street were proven wrong but the market was able to recover throughout the day with the S&P/ASX 200 index ending up 0.2 per cent at 5761.4 points.
SNDFY GEM MS.PRE MS.PRF MS.PRG MS.PRA RFG MS.PRI SFRRF MS.PRK SFR RFGPF MS WNARF WSA

0
Former G8 Education chair Jennifer Hutson faces charges

2018-04-03 theage.com.au
The former chairperson of childcare provider G8 Education is facing charges including giving false information and dishonest use of her position in relation to an abandoned takeover bid launched by G8 in 2015.
GEM

2
Former G8 Education chair Jennifer Hutson faces charges

2018-04-03 smh.com.au
The former chairperson of childcare provider G8 Education is facing charges including giving false information and dishonest use of her position in relation to an abandoned takeover bid launched by G8 in 2015.
GEM

0
G8 Education's former chairwoman faces 25 years in jail

2018-04-03 smh.com.au
Jenny Hutson, the former chairwoman of childcare provider G8 Education, faces up to 25 years in jail after being charged with attempting to pervert the course of justice following an ASIC investigation of G8's takeover bid for Affinity Education Group in 2015.
LNCYF LNCGY GEM TI6

0
G8 Education's former chairwoman faces 25 years in jail

2018-04-03 theage.com.au
Jenny Hutson, the former chairwoman of childcare provider G8 Education, faces up to 25 years in jail after being charged with attempting to pervert the course of justice following an ASIC investigation of G8's takeover bid for Affinity Education Group in 2015.
LNCYF LNCGY GEM TI6

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:GEM / G8 EDUCATION LIMITED on message board site Silicon Investor.

Gemalto N.V. Brookfield Asset Management
XRAY - Undiscovered Gem Apptio APTI Business management software
gem-xu0027s incredibly accurate Elliott Wave forecasts. Health Management Systems, Inc. (HMSY)- Great BuY!
MANH -- leadership in supply-chain management Logistics / Supply Chain Management (SCM) Industry
Facebook Gems u0026 Delights Gemstar Intl (GMST)